Chronic Plaque Psoriasis Market è segmentato da Drug Class (Biologics, Small Molecule Drugs), da Route of Administration (Injectable, Oral, Topical), da Geografia (Americ ....
I principali attori del Chronic Plaque Psoriasis Market includono Novartis AG, Eli Lilly e Company, AbbVie Inc., Johnson & Johnson (Janssen Biotech), Amgen Inc., UCB S.A., Celgene Corporation, Merck & Co., Inc., Pfizer Inc. e Biogen Inc.
Mercato della psoriasi cronica